Research in the Chapkin lab focuses on dietary/microbial modulators related to the prevention of cancer and chronic inflammatory diseases. The lab has been continuously funded by the National Institutes of Health (NIH) for the past 35 years.
Most Recent NIH Award: Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
TEXAS Regional Center of Excellence in Cancer Research – TREC
The Chapkin Lab is excited to work with the Single Cell Science Data Core established through the Texas Regional Center of Excellence in Cancer Research – TREC.
cancer. tamu.edu *site under construction
NEWS:
- Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
Major Goals: Annotate host exfoliated mucosal cell transcriptome, i.e., exfoliome, and fecal bacterial metagenome and … Read more - Texas A&M University Faculty Affairs
Congratulates Dr. Robert Chapkin for ASN Award - BREAKTHROUGH IN Wnt SIGNALING PUBLISHED!
Breakthrough publication! Our recent paper in Nature Communications explains the novel structure-function mechanism by which … Read more - Have a 2nd Cup of Coffee
Have a second cup: Coffee provides health benefits Review paper outlines Texas A&M research on … Read more - Texas A&M receives $6 million to create Center of Excellence in Cancer
Texas A&M receives $6 million to create Center of Excellence in Cancer Five-year grant from … Read more
FOLLOW US ON X (Twitter) @ChapkinLab
Congrats to the 2023 Mary Swartz Rose Investigator Awardees, shown here at the @nutritionorg #Nutrition2023 event in Boston yesterday! These awards are given for outstanding #research on the #safety & efficacy of bioactive compounds for human #health. https://t.co/RtGTwMQRrN pic.twitter.com/phLIP6JzyA— CRN (@CRN_Supplements) July 24, 2023
Mutant APC reshapes Wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic β-catenin https://t.co/wxCT8liokp— The Chapkin Lab (@ChapkinLab) August 23, 2023